Tag : Therapeutics

Latest News

Relief Therapeutics (RLF:SIX) – Le médicament Aviptadil entame un essai de la FDA à l’hôpital universitaire Thomas Jefferson de Philadelphie, pour traiter le syndrome de détresse respiratoire aiguë induit par la COVID-19

Newsemia
GENÈVE–(BUSINESS WIRE)–RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” annonce que son médicament Aviptadil est maintenant entré dans la phase d’essais cliniques de la FDA à l’hôpital...
Latest News

A Message from Akebia Therapeutics, Inc.’s Chief Executive Officer to Our Patients, Healthcare Providers, and Other Stakeholders During the Rapidly Evolving COVID-19 Pandemic:

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–At Akebia Therapeutics, the health of our patients and employees is our first priority. As a member of the kidney care community and...
Latest News

RELIEF THERAPEUTICS Holding SA (SIX : RLF) annoncera la proposition de nomination à la vice-présidence du conseil d’administration du Prof. Jonathan Javitt, M.D., M.P.H., lors de la prochaine assemblée générale

Newsemia
GENÈVE–(BUSINESS WIRE)–RELIEF THERAPEUTICS Holding SA (SIX-RLF, “Relief” ou la “Société”) annonce aujourd’hui que le Prof. Jonathan C. Javitt, DM, MPH sera proposé à l’élection du...
Latest News

Global Post-traumatic Stress Disorder (PSTD) Therapeutics Market 2020-2024 | Evolving Opportunities with AstraZeneca Plc and Azevan Pharmaceuticals Inc. | Technavio

Newsemia
LONDON–(BUSINESS WIRE)– #GlobalPosttraumaticStressDisorderTherapeuticsMarket–The post-traumatic stress disorder therapeutics market will grow by USD 909.86 million during 2020-2024 Source link...
Latest News

BMS, Voluntis partner on digital therapeutics for cancer patients

Newsemia
The companies will develop a mobile app that will allow patients to self-manage symptoms and enable remote monitoring by healthcare providers. In a phone interview,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy